The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a significant increase in cerebrospinal meningitis cases, recording 4,915 suspected cases and 361 deaths across 24 states during the 2023/2024 season. This marks a 157% rise compared to the previous season's 1,914 cases.
Dr. Jide Idris, the Director-General of the NCDC, provided a detailed breakdown of the situation:
-
Sample Collection and Confirmation: Out of 859 samples collected from suspected cases, 378 were confirmed positive, indicating a 44% positivity rate.
-
Predominant Strain: Neisseria meningitidis serogroup C has been identified as the predominant strain, accounting for 90% of confirmed cases.
-
Demographics: The most affected age group is between 5 to 15 years, with males constituting 60% of the total suspected cases.
-
Geographical Impact: The five most affected states are Yobe (3,014 cases), Bauchi (517 cases), Jigawa (389 cases), Katsina (352 cases), and Gombe (316 cases), collectively accounting for 93% of all reported cases.
In response to the escalating outbreak, Nigeria has received over one million vaccines from the Gavi-funded global stockpile to combat the disease, particularly in the northern regions. Health Minister Muhammad Ali Pate emphasized that the arrival of these vaccines is a crucial milestone in Nigeria's response to the current meningitis outbreak. The World Health Organization has also underscored the importance of these vaccines in preventing future outbreaks and safeguarding public health.
The NCDC continues to collaborate with state health authorities and international partners to enhance surveillance, conduct vaccination campaigns, and implement public health measures aimed at controlling the spread of meningitis. Citizens are advised to seek immediate medical attention if they experience symptoms such as sudden fever, severe headache, neck stiffness, nausea, and sensitivity to light.